- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | CMA pins down Tiofarma for illegal market sharing | ||
| Fr | 75% drop in cases from UK meningitis B vaccine | ||
| Fr | Tagrisso hit with NICE rejection for NSCLC | ||
| Fr | Video games encouraging 'under the radar' gambling | ||
| Fr | Opportunity awaits in the 2020 Clinical Researcher of the Year - The Americas competition | ||
| Do | Could beta-blockers slow the spread of cancer? | ||
| Do | Robotic heart, heart attack vaccine among BHF Big Beat finalists | ||
| Do | Cervical screening numbers hit 'new low' | ||
| Do | QiC Dermatology now open for entries | ||
| Mi | 'Make use of community pharmacists', NICE urges | ||
| Mi | Sunosi approved in Europe for narcolepsy, sleep apnoea | ||
| Mi | PhoreMost enlists Otsuka in multi-project drug discovery collab | ||
| Mi | NICE rejects Janssen's Stelara on cost efficiency grounds | ||
| Mi | Darzalex EU nod marks first newly diagnosed MM treatment in six years | ||
| Di | Fight for Sight to fund macular degeneration research | ||
| Di | EU clears Roche's Polivy for certain lymphomas | ||
| Di | EMA licenses Mayzent for MS | ||
| Mo | New scan could see active breast tumour regions in 'real-time' | ||
| Mo | 'Weak antibiotic pipeline' poses threat to AMR fight | ||
| Mo | HIV transmissions fall by 71% | ||
| Mo | Heart failure market could surpass '$22bn by 2028' | ||
| Mo | INTCR 2020 closing for entry midnight on Thursday | ||
| 17.01. | Ibrance given NICE green light in breast cancer | ||
| 17.01. | Government health commitments just a 'pipedream' | ||
| 17.01. | Vitrakvi deemed 'not cost-effective' by NICE |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
